Environmental

LIVN’s R&D intensity at 13.8% of revenue supports product innovation with relatively limited direct environmental footprint versus manufacturing-heavy medtech peers.

The company’s low leverage reduces balance-sheet pressure that can otherwise constrain funding for environmental compliance and facility-efficiency investments versus more indebted peers.

No disclosed emissions, energy, or waste metrics were provided, limiting evidence of superior environmental management relative to peers with more transparent reporting.

As a medical-device company, LIVN’s environmental exposure is mainly indirect through suppliers and product lifecycle, which is typically less material than for industrial peers.

Social

LIVN’s R&D-to-revenue ratio of 13.8% indicates sustained investment in clinically relevant innovation, which can support patient outcomes versus less research-intensive peers.

Stock-based compensation at 3.0% of revenue suggests moderate talent retention costs, which is generally more disciplined than peers with heavier equity dilution.

The absence of provided workforce, safety, and product-quality disclosures prevents a fuller assessment, but no data indicates a peer-level social controversy or structural weakness.

In medtech, product reliability and clinical trust are material social factors, and LIVN’s capital allocation suggests a stable operating base for maintaining those standards.

Governance

Debt-to-equity of 0.27 and net debt to EBITDA of -0.91 indicate conservative capital structure, reducing governance risk from financial stress versus more leveraged peers.

Stock-based compensation at 3.0% of revenue appears controlled, which supports alignment and limits dilution concerns relative to peers with more aggressive equity pay.

The provided metrics do not show governance red flags such as excessive leverage or weak capital discipline, supporting a stronger relative governance profile.

Limited disclosure on board independence, audit oversight, and ethics controls constrains a higher score, but available capital metrics remain favorable versus peers.

Overall Score

LIVN’s ESG positioning is strongest on governance and social factors, where disciplined capital structure and sustained R&D investment compare favorably with peers.

Score Driver: Conservative Leverage And Sustained R&D Investment Versus Peers